Balixafortide

DB15370InvestigationalProtein Based Therapies

Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).

Mechanism: Pharmacologically active on C-X-C chemokine receptor type 4
Curator reviewed
Code names: POL6326

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Balixafortide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.